Vor Biopharma Inc.
VOR
$2.17
-$0.03-1.36%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 133.38% | -44.14% | -32.99% | -60.77% | -54.02% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -62.93% | 17.85% | 33.24% | 14.40% | 2.38% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 952.21% | -41.42% | -20.00% | -57.27% | -49.54% |
| Total Current Assets | 127.05% | -42.01% | -31.46% | -59.08% | -52.84% |
|
|
|||||
| Total Current Assets | 127.05% | -42.01% | -31.46% | -59.08% | -52.84% |
| Net Property, Plant & Equipment | -99.95% | -17.29% | -16.99% | -15.97% | -14.94% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -92.33% | -33.88% | -33.62% | -24.22% | -3.61% |
| Total Assets | 45.05% | -34.56% | -27.88% | -47.99% | -43.59% |
|
|
|||||
| Total Accounts Payable | -66.67% | 60.52% | 84.66% | 0.53% | 21.78% |
| Total Accrued Expenses | 656.46% | 25.31% | 17.98% | -14.22% | 4.42% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 7.81% | 10.05% | 11.22% | 11.43% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 325.86% | 26.60% | 19.52% | -6.78% | 8.52% |
|
|
|||||
| Total Current Liabilities | 325.86% | 26.60% | 19.52% | -6.78% | 8.52% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -13.86% | -13.24% | -12.67% | -12.16% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3,832.77% | -1.71% | -2.48% | -10.79% | -6.51% |
|
|
|||||
| Common Stock & APIC | 12.19% | 12.45% | 12.78% | 2.10% | 2.34% |
| Retained Earnings | -417.44% | -31.98% | -34.38% | -35.84% | -42.08% |
| Treasury Stock & Other | 120.00% | 126.44% | 128.57% | 124.29% | 83.94% |
| Total Common Equity | -1,635.18% | -46.30% | -35.87% | -58.26% | -52.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1,635.18% | -46.30% | -35.87% | -58.26% | -52.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1,635.18% | -46.30% | -35.87% | -58.26% | -52.03% |
|
|
|||||